US Broker Ratings

ResMed Inc. (RMD) Stock Analysis: A Look at a 17.83% Potential Upside for Healthcare Investors

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a solid market capitalization..

Tempus AI, Inc. (TEM) Stock Analysis: A Healthcare Tech Powerhouse with 48% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM), a pivotal player in the healthcare technology sector, has garnered significant attention in the investment community due to its innovative approach..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking the 111.52% Potential Upside

Telix Pharmaceuticals Limited (TLX) is capturing the attention of investors, not just in Australia but globally, due to its ambitious pipeline in the biotechnology sector. With..

Doximity, Inc. (DOCS) Stock Analysis: Evaluating a 17.70% Potential Upside in Healthcare Innovation

Doximity, Inc. (DOCS) presents an intriguing prospect for investors looking to tap into the burgeoning field of digital health services. As a dominant player in the..

The Ensign Group, Inc. (ENSG): Investor Outlook with a 23.48% Potential Upside

Investors eyeing The Ensign Group, Inc. (NASDAQ: ENSG) might find its current market position appealing, as a confluence of factors suggests potential upside. With a robust..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: 87.96% Potential Upside Beckons Investors

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is a pioneering biotechnology company at the forefront of ribonucleic acid interference (RNAi) therapeutics development. With a robust pipeline and an..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook on a Biotech Stock with a 29% Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM) stands out as an intriguing player in the biotechnology sector, primarily focused on developing therapies for central nervous system (CNS) disorders...

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Promising Biotech with a 10.38% Upside Potential

In the fast-evolving world of biotechnology, Revolution Medicines, Inc. (NASDAQ: RVMD) stands out as a formidable player with a focus on precision oncology. This Redwood City,..

ICON plc (ICLR) Stock Analysis: Evaluating Performance & 13.45% Potential Upside

ICON plc (NASDAQ: ICLR), a leading clinical research organization headquartered in Dublin, Ireland, is making waves in the healthcare sector with its expansive range of outsourced..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 7.62% Upside Potential in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (SNN), a prominent player in the healthcare sector, commands significant attention from investors due to its robust presence in the medical..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A 46% Potential Upside Amid Robust Analyst Support

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, has caught the attention of investors with its promising potential upside and robust analyst..

Universal Health Services, Inc. (UHS) Stock Analysis: A Closer Look at Its 15% Potential Upside

Universal Health Services, Inc. (NYSE: UHS), headquartered in King of Prussia, Pennsylvania, is a prominent player in the healthcare sector, specifically within the medical care facilities..

Moderna, Inc. (MRNA) Stock Analysis: Exploring a 9.75% Potential Downside in the Biotech Leader

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has been a focal point for investors due to its pioneering work in mRNA technology...

HealthEquity, Inc. (HQY) Stock Analysis: A 17.81% Upside Potential with Strong Buy Ratings

Investors eyeing the healthcare sector might find HealthEquity, Inc. (NASDAQ: HQY) a compelling opportunity, especially with its robust buy ratings and promising upside potential. As a..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 72% Potential Upside Amidst Challenging Metrics

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leader in the biotechnology sector, is making waves in the healthcare industry with its innovative RNA-targeted therapies. While the company..

Amgen Inc. (AMGN) Investor Outlook: Analyzing the 101% Return on Equity and Market Position

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture investor attention with its robust market presence and impressive financial indicators. As a..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring the 40.99% ROE and Analyst Consensus

Exelixis, Inc. (NASDAQ: EXEL), a key player in the biotechnology sector, is capturing investor attention with its robust return on equity (ROE) of 40.99%. Specializing in..

Viatris Inc. (VTRS) Stock Analysis: Navigating the Healthcare Giant’s Potential Upside Amid Market Volatility

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, is navigating a complex landscape with strategic agility. As a leading entity within the Drug..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 28% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, United Therapeutics Corporation (NASDAQ: UTHR) presents a compelling case with its robust product portfolio and significant upside potential...

Incyte Corporation (INCY) Stock Analysis: A Look at the Biotechnology Leader’s Growth Potential

Incyte Corporation (NASDAQ: INCY), with its substantial market capitalization of $24.23 billion, stands tall in the biotechnology industry. Headquartered in Wilmington, Delaware, Incyte has carved a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds